Voriconazole Pharmacokinetics Administered at 4 mg/kg IM and IV in Nursehound Sharks (<i>Scyliorhinus stellaris</i>) Under Human Care
Fungal diseases, despite their low incidence in sharks and rays, are considered emerging diseases in this group of animals and can lead to high mortality rates despite treatment. The information available related to the treatment of fungal diseases in elasmobranchs is limited and is frequently based...
Saved in:
Main Authors: | Daniela Cañizares-Cooz, Daniel García-Párraga, Sonia Rubio-Langre, Teresa Encinas, Pablo Morón-Elorza |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Veterinary Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-7381/12/1/17 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Voriconazole-induced periostitis in the hand
by: Gurbinder Singh, et al.
Published: (2025-03-01) -
Development of single-pin, un-barbed, pole-tagging of free-swimming dolphins and sharks with satellite-linked transmitters
by: Michael J. Moore, et al.
Published: (2024-04-01) -
A Secure Image Steganography Using Shark Smell Optimization and Edge Detection Technique
by: Omar Y. Abdulhammed, et al.
Published: (2022-10-01) -
Unusual presence of atlantic sharpnose shark (Rhizoprionodon terraenovae) neonates in a coastal lagoon in southeast Gulf of Mexico
by: Armando T. Wakida-Kusunoki, et al.
Published: (2025-01-01) -
Safety and recommendation of voriconazole for invasive pulmonary aspergillosis in severe liver disease patients: a retrospective cohort study
by: Xin Zhang, et al.
Published: (2025-01-01)